Ballow, M <br/><br/>
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).  [electronic resource] 

 -  Vox sanguinis  Apr 2003 
 - 202-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0042-9007 
<br/><br/><label>Standard No.: </label>10.1046/j.1423-0410.2003.00286.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Asthenia--chemically induced<br/>Caprylates<br/>Female<br/>Glycine<br/>Half-Life<br/>Humans<br/>Immunoglobulins, Intravenous--pharmacokinetics<br/>Immunologic Deficiency Syndromes--complications<br/>Male<br/>Maltose<br/>Pharmacokinetics<br/>Therapeutic Equivalency<br/>Treatment Outcome